Drug discovery and development for neglected diseases: the DNDi model
Open Access
- 1 March 2011
- journal article
- review article
- Published by Taylor & Francis Ltd in Drug Design, Development and Therapy
- Vol. 5, 175-81
- https://doi.org/10.2147/dddt.s16381
Abstract
Peer reviewed article authored by (Eric Chatelain, Jean-Robert Ioset). Read article or submit your manuscript for publishing.Keywords
This publication has 15 references indexed in Scilit:
- Fexinidazole – A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping SicknessPLoS Neglected Tropical Diseases, 2010
- “Manifesto” for Advancing the Control and Elimination of Neglected Tropical DiseasesPLoS Neglected Tropical Diseases, 2010
- Neglected tropical diseasesBritish Medical Bulletin, 2009
- Advancing Drug Innovation for Neglected Diseases—Criteria for Lead ProgressionPLoS Neglected Tropical Diseases, 2009
- Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease BurdenPLoS Neglected Tropical Diseases, 2009
- Neglected Disease Research and Development: How Much Are We Really Spending?PLoS Medicine, 2009
- Measuring the Burden of Neglected Tropical Diseases: The Global Burden of Disease FrameworkPLoS Neglected Tropical Diseases, 2007
- Public-private partnership: from there to hereTransactions of the Royal Society of Tropical Medicine and Hygiene, 2005
- A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We NeedPLoS Medicine, 2005
- New Drugs for Neglected Diseases: From Pipeline to PatientsPLoS Medicine, 2004